Novo Taps OpenAI to Speed Development of New Obesity Drugs
Novo Nordisk A/S will integrate OpenAI’s artificial intelligence across the company to accelerate drug development.
Novo Nordisk partners with OpenAI
- Novo Nordisk teams up with OpenAI to boost AI-driven drug discovery efforts Seeking Alpha —
- Novo Nordisk and OpenAI Partner to Speed Drug Discovery Wall Street Journal —
- Novo Nordisk partners with OpenAI as AI drug discovery hopes mount CNBC —
- Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters Reuters —